129 related articles for article (PubMed ID: 12104043)
1. Pervilleines B and C, new tropane alkaloid aromatic esters that reverse the multidrug-resistance in the hollow fiber assay.
Mi Q; Cui B; Silva GL; Lantvit D; Lim E; Chai H; Hollingshead MG; Mayo JG; Kinghorn AD; Pezzuto JM
Cancer Lett; 2002 Oct; 184(1):13-20. PubMed ID: 12104043
[TBL] [Abstract][Full Text] [Related]
2. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
Mi Q; Cui B; Silva GL; Lantvit D; Lim E; Chai H; You M; Hollingshead MG; Mayo JG; Kinghorn AD; Pezzuto JM
Cancer Res; 2001 May; 61(10):4030-7. PubMed ID: 11358822
[TBL] [Abstract][Full Text] [Related]
3. Pervilleine F, a new tropane alkaloid aromatic ester that reverses multidrug resistance.
Mi Q; Cui B; Lantvit D; Reyes-Lim E; Chai H; Pezzuto JM; Kinghorn AD; Swanson SM
Anticancer Res; 2003; 23(5A):3607-15. PubMed ID: 14666656
[TBL] [Abstract][Full Text] [Related]
4. Characterization of tropane alkaloid aromatic esters that reverse the multidrug-resistance phenotype.
Mi Q; Cui B; Chávez D; Chai H; Zhu H; Cordell GA; Hedayat S; Kinghorn AD; Pezzuto JM
Anticancer Res; 2002; 22(3):1385-97. PubMed ID: 12168815
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the multidrug-resistance phenotype by new tropane alkaloid aromatic esters from Erythroxylum pervillei.
Silva GL; Cui B; Chávez D; You M; Chai HB; Rasoanaivo P; Lynn SM; O'Neill MJ; Lewis JA; Besterman JM; Monks A; Farnsworth NR; Cordell GA; Pezzuto JM; Kinghorn AD
J Nat Prod; 2001 Dec; 64(12):1514-20. PubMed ID: 11754602
[TBL] [Abstract][Full Text] [Related]
6. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.
Anuchapreeda S; Leechanachai P; Smith MM; Ambudkar SV; Limtrakul PN
Biochem Pharmacol; 2002 Aug; 64(4):573-82. PubMed ID: 12167476
[TBL] [Abstract][Full Text] [Related]
7. Reversal of multidrug resistance by tropane alkaloids from the stems of Erythroxylum rotundifolium.
Chávez D; Cui B; Chai HB; García R; Mejía M; Farnsworth NR; Cordell GA; Pezzuto JM; Kinghorn AD
J Nat Prod; 2002 Apr; 65(4):606-10. PubMed ID: 11975514
[TBL] [Abstract][Full Text] [Related]
8. Sensitization of multidrug resistant (MDR) cancer cells to vinblastine by novel acridones: correlation between anti-calmodulin activity and anti-MDR activity.
Mayur YC; Padma T; Parimala BH; Chandramouli KH; Jagadeesh S; Gowda NM; Thimmaiah KN
Med Chem; 2006 Jan; 2(1):63-77. PubMed ID: 16787357
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and chemical characterization of 2-methoxy-N(10)-substituted acridones needed to reverse vinblastine resistance in multidrug resistant (MDR) cancer cells.
Krishnegowda G; Thimmaiah P; Hegde R; Dass C; Houghton PJ; Thimmaiah KN
Bioorg Med Chem; 2002 Jul; 10(7):2367-80. PubMed ID: 11983534
[TBL] [Abstract][Full Text] [Related]
10. Saturable function of P-glycoprotein as a drug-efflux pump in multidrug-resistant tumour cells.
Miyamoto KI; Koga-Takeda K; Koga K; Ohshima T; Nomura M
J Pharm Pharmacol; 1996 May; 48(5):522-5. PubMed ID: 8799879
[TBL] [Abstract][Full Text] [Related]
11. Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro.
Naoe Y; Inami M; Takagaki S; Matsumoto S; Kawamura I; Nishigaki F; Tsujimoto S; Manda T; Shimomura K
Jpn J Cancer Res; 1998 Oct; 89(10):1047-54. PubMed ID: 9849584
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
13. Is rhodamine 123 an appropriate fluorescent probe to assess P-glycoprotein mediated multidrug resistance in vinblastine-resistant CHO cells?
Pétriz J; O'Connor JE; Carmona M; García-López J
Anal Cell Pathol; 1997; 14(3):129-40. PubMed ID: 9354229
[TBL] [Abstract][Full Text] [Related]
14. Expression, subcellular distribution and response to phorbol esters of protein kinase C (PKC) isozymes in drug-sensitive and multidrug-resistant KB cells evidence for altered regulation of PKC-alpha.
Cloud-Heflin BA; McMasters RA; Osborn MT; Chambers TC
Eur J Biochem; 1996 Aug; 239(3):796-804. PubMed ID: 8774728
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract.
Limtrakul P; Khantamat O; Pintha K
Cancer Chemother Pharmacol; 2004 Dec; 54(6):525-30. PubMed ID: 15248030
[TBL] [Abstract][Full Text] [Related]
16. MDR-1 gene expression is a minor factor in determining the multidrug resistance phenotype of MCF7/ADR and KB-V1 cells.
Kim HM; Oh GT; Hong DH; Kim MS; Kang JS; Park SM; Han SB
FEBS Lett; 1997 Jul; 412(1):201-6. PubMed ID: 9257720
[TBL] [Abstract][Full Text] [Related]
17. Influence of vinblastine on DNA parameters and multidrug resistance in renal cell carcinoma in vitro.
Domagk D; Blüthner-Hässler C; Kugler A; Kallerhoff M; Ringert RH
Urol Res; 1998; 26(2):123-7. PubMed ID: 9631945
[TBL] [Abstract][Full Text] [Related]
18. Non-glucocorticoid steroid analogues (21-aminosteroids) sensitize multidrug resistant cells to vinblastine.
Abraham I; Wolf CL; Sampson KE
Cancer Chemother Pharmacol; 1993; 32(2):116-22. PubMed ID: 8097968
[TBL] [Abstract][Full Text] [Related]
19. Purification and reconstitution of human P-glycoprotein.
Ambudkar SV; Lelong IH; Zhang J; Cardarelli C
Methods Enzymol; 1998; 292():492-504. PubMed ID: 9711577
[TBL] [Abstract][Full Text] [Related]
20. Selective modulation of P-glycoprotein-mediated drug resistance.
Bebawy M; Morris MB; Roufogalis BD
Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
